Overview

The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of gemcabene on insulin sensitivity as defined by average glucose disposal rate.
Phase:
Phase 2
Details
Lead Sponsor:
Gemphire Therapeutics, Inc.
NeuroBo Pharmaceuticals Inc.
Treatments:
Insulin